A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
Titel:
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
Auteur:
Harbeck, Nadia Saupe, Steffen Jäger, Elke Schmidt, Marcus Kreienberg, Rolf Müller, Lothar Otremba, Burkhard Joerg Waldenmaier, Dirk Dorn, Julia Warm, Mathias Scholz, Michael Untch, Michael Wit, Maike de Barinoff, Jana Lück, Hans-Joachim Harter, Philipp Augustin, Doris Harnett, Paul Beckmann, Matthias W. Al-Batran, Salah-Eddin